June 25, 2025
Mr. McGarvey (for himself and Mr. Bilirakis) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend title XVIII of the Social Security Act to provide for adjustments to the Medicare part D cost-sharing reductions for low-income individuals.
Section 1. Short title
This Act may be cited as the Cutting Copays Act
.
Sec. 2. Adjustments to Medicare part D cost-sharing reductions for low-income individuals
Section 1860D–14(a) of the Social Security Act (42 U.S.C. 1395w–114(a)) is amended in paragraph (1)(D)(ii)—
(1)
by striking that does not exceed $1 for
and all that follows through the period at the end and inserting
that does not exceed—
(I)
for plan years before plan year 2026—
(aa)
for a generic drug or a preferred drug that is a multiple source drug (as defined in section 1927(k)(7)(A)(i)), $1 or, if less, the copayment amount applicable to an individual under clause (iii); and
(bb)
for any other drug, $3 or, if less, the copayment amount applicable to an individual under clause (iii); and; and
(2)
by adding at the end the following new subclauses:
(II)
for plan year 2026—
(aa)
for a generic drug, $0; and
(bb)
for any other drug, the dollar amount applied under this clause (after application of paragraph (4)(A)) for plan year 2023 for a drug described in subclause (I)(bb); and
(III)
for a subsequent year, the dollar amount applied under this clause for the previous year for the drug, increased by the annual percentage increase in the consumer price index (all items; U.S. city average) as of September of such previous year.